Baxter is executing a portfolio simplification with the Kidney Care (Vantive) separation completing, leaving a focused medical products and pharmaceuticals business. Debt reduction from divestiture proceeds improves the balance sheet. Hurricane Helene IV fluid plant disruption has been resolved but margin recovery is gradual. Limited near-term catalysts beyond execution.
Thesis reviewed May 29, 2026
Baxter International Inc. is headquartered in United States, which is currently showing moderate signals.
πΊπΈUnited States60NEUTRALView United States risk detail βπ₯Healthcare28NEUTRAL| Ticker | Company | Score | Gap | Signal Ξ | Action |
|---|---|---|---|---|---|
| UNH | UnitedHealth Group Inc. | 32 | +16% | β3% | AVOID |
| CVS | CVS Health Corporation | 32 | +15% | β3% | AVOID |
| ELV | Elevance Health Inc. | 32 | +7% | β3% | NEUTRAL |
| SYK | Stryker Corporation | 32 | +15% | β3% | EARLY |
| TEVA | Teva Pharmaceutical Industries Ltd. | 32 | +9% | β3% | NEUTRAL |
| DHR | Danaher Corporation | 32 | +11% | β3% | EARLY |
| TMO | Thermo Fisher Scientific Inc. | 32 | +11% | β3% | EARLY |
Investors who hold BAX may also have indirect exposure through these country funds.
Baxter completes Vantive Kidney Care spin transaction
North Cove plant returns to full IV fluid production
Estimates Β· Yahoo Finance Β· Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Debbie Wasserman SchultzFL | D | Buy | $1kβ$15k | Nov 18, 24 | -41.0% |
| Earl BlumenauerOR | Buy | Unknown amount | Jul 9, 24 | -47.5% |